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Follicle-stimulating hormone (FSH) is a central regulator of male and female reproductive
function. Over the last decade, there has been a growing perception of the complexity asso-
ciated with FSH-induced cellular signaling. It is now clear that the canonical Gs/cAMP/PKA
pathway is not the sole mechanism that must be considered in FSH biological actions.
In parallel, consistent with the emerging concept of biased agonism, several examples
of ligand-mediated selective signaling pathway activation by gonadotropin receptors have
been reported. In this context, it is important to gain an integrative view of the signaling
pathways induced by FSH and how they interconnect to form a network. In this review,
we propose a ﬁrst attempt at building topological maps of various pathways known to be
involved in the FSH-induced signaling network. We discuss the multiple facets of FSH-
induced signaling and how they converge to the hormone integrated biological response.
Despite of their incompleteness, these maps of the FSH-induced signaling network repre-
sent a ﬁrst step toward gaining a system-level comprehension of this hormone’s actions,
which may ultimately facilitate the discovery of novel regulatory processes and therapeutic
strategies for infertility and non-steroidal contraception.
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INTRODUCTION
Follicle-stimulating hormone (FSH) plays a central role in the con-
trol of reproduction. FSH is a heterodimeric pituitary glycoprotein
consisting of an α-subunit, which is common to other glycopro-
tein hormones, and a speciﬁc β-subunit (Papkoff and Ekblad,
1970). FSH binds to and activates the FSH receptor (FSHR),which
belongs to the 7 transmembrane domains receptor (7TMR) family,
also known asGprotein-coupled receptors. The FSHR is expressed
in Sertoli cells in testis and granulosa cells in ovaries (Simoni
et al., 1997). FSH is required for normal growth and maturation
of ovarian follicles in women and for normal spermatogenesis in
men (Themmen and Huhtaniemi, 2000). Knock-out of the FSH
β-subunit or the FSHR genes in mice result in signiﬁcant repro-
ductive defects in both sexes (Kumar et al., 1997; Dierich et al.,
1998). Consistently, inactivating mutations in either FSH β sub-
unit or FSHR led to similar reproductive defects (Matthews et al.,
1993;Aittomaki et al., 1995; Layman et al., 1997;Huhtaniemi et al.,
2006). Depending on the physiological situation, FSH has to con-
trol distinct, sometime opposite, integrated biological responses in
its target cells, ranging from differentiation, cellular metabolism,
steroidogenesis, proliferation, and apoptosis (Dias et al., 2010).
Due to its ability to control reproduction, either native or
recombinant FSH preparations have been extensively used in
reproductive medicine and animal breeding (Lunenfeld, 2004;
Macklon et al., 2006). However, the use of FSH remains associated
with signiﬁcant drawbacks such as the risk of triggering ovar-
ian hyperstimulation syndrome (OHSS; Vloeberghs et al., 2009)
or heterogeneous responsiveness (Loutradis et al., 2003, 2004).
Conversely, it has been proposed that FSHR blockers could poten-
tially represent a novel non-steroidal approach for contraception
(Naz et al., 2005). A causal role of FSH in the etiology of ovarian
epithelial cancer has also been proposed many years ago (Choi
et al., 2007). In addition, it has been recently reported that FSHR
is ectopically expressed by endothelial cells associated with the
angiogenesis of a wide panel of tumors, pointing out to the FSHR
as a common marker for early diagnosis of most cancers (Radu
et al., 2010). In addition, this ﬁnding also raises the intriguing pos-
sibility of a direct role played by FSH in promoting early tumoral
angiogenesis. In this general context, selective pharmacological
modulators of FSHR would be of great interest.
Noteworthy, it is increasingly accepted that certain ligands can
lead to selective activation of signaling pathways by binding at
their cognate 7TMRs in a process referred to as biased agonism
(Kenakin, 2005; Rajagopal et al., 2010; Whalen et al., 2011). In
line with this emerging concept, it has been recently reported that
certain hormone glycosylation variants, potentiating antibodies
and small molecule ligands can trigger biased responses at the
FSHR (Arey et al., 2008; Wehbi et al., 2010a,b; Dias et al., 2011;
Ulloa-Aguirre et al., 2011). It has also been shown that FSHR can
be directly stimulated by antibodies, expending even more the
potential to develop biased agonists at this receptor (Agrawal and
Dighe, 2009). Paralleling the notion of biased agonism, it is now
generally accepted that the canonical G protein-dependent cou-
pling is not the unique mechanism leading to 7TMRs signaling
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(Lefkowitz and Shenoy, 2005; Reiter and Lefkowitz, 2006). The
FSHR coupling to the classical Gαs/cAMP/protein kinase A (PKA)
signaling pathway, which had been acknowledged as the sole effec-
tor mechanism of FSH for more than 20 years, is now viewed as
one of severalmechanisms contributing to the activation of a com-
plex integrated signaling network. Deciphering the organization
and dynamic functioning of this network is an important chal-
lenge that the ﬁeld has now to address as it may help identify novel
regulatory processes and therapeutic strategies for infertility and
non-steroidal contraception.
In the present review paper, we attempted to integrate the data
available onFSH-induced signaling by building a series of topolog-
icalmaps in theCellDesignermodeling environment (Kitano et al.,
2005). CellDesigner is a structured diagram editor for drawing
biochemical and gene-regulatory networks. Networks are drawn
based on the graphical notation system proposed by Kitano et al.
(2005). Models are stored using the Systems Biology Markup
Language (SBML), a standard for representing models of bio-
chemical and gene-regulatory networks. Because they are coded
in SBML, CellDesigner models are easily shared or linked with
simulation and other analysis packages through Systems Biology
Workbench (SBW). For each reaction, the relevant references are
indicated within the network representation, providing a unique
and user-friendly integration of the available knowledge. For sim-
pliﬁcation purpose, we chose to only represent monomers in
the maps throughout the paper although it is now well estab-
lished that FSHR is expressed as dimers at the plasma membrane
(Thomas et al., 2007; Guan et al., 2010). In the future, as the data
become more abundant, it will be possible and more rigorous to
draw separate models for each physiological situation (i.e., Ser-
toli vs. granulosa cells, young vs. mature, as a function of the
species, endogenous vs. heterogeneously expressed receptors, etc.).
However, in the present paper, in order to deal with the relative
scarcity of available data for certain mechanisms, we decided to
aggregate data even if they were generated in different cellular
models.
MULTIPLE TRANSDUCTION MECHANISMS ARE ACTIVATED
BY FSH
The Gαs/cAMP/PKA signaling pathway has been considered for
more than 20 years as the key mechanism relaying FSH biologi-
cal action inside target cells (Means et al., 1974; Dattatreyamurty
et al., 1987). However, it is now amply documented that FSHR
also engages other transduction mechanisms upon FSH binding.
Figure 1 shows, in CellDesigner format, the known G protein-
dependent and -independent transduction mechanisms engaged
at the FSHR.
Early assumption of Gαs/cAMP/PKA-independent signaling at
the FSHR comes from the observation that adenovirus-mediated
transduction of a constitutively active Gαs (Gαs Q227L) in
undifferentiated rat granulosa cells was not capable of inducing
the expression of differentiation markers such as aromatase or
luteinizing hormone receptor (Zeleznik et al., 2003). Overexpres-
sion of a constitutively active form of protein kinase B (PKB/Akt)
was required to fully restore the expression of these two markers
(Zeleznik et al., 2003). Besides, PKB activation had been reported
to depend in some instance on cAMP (Meroni et al., 2002; Alam
et al., 2004), independently of PKA (Gonzalez-Robayna et al.,
2000), suggesting that exchange protein directly activated by cAMP
(EPAC) was also involved in the process. A role for EPAC in FSH
biological action has been later demonstrated (Wayne et al., 2007).
To conclude, PKB seems to be activated both by Gαs-dependent
mechanisms, likely via EPAC, and by Gαs-independent mecha-
nisms, in FSH-stimulated cells. Interestingly, quantitatively weaker
gene expression was observed with a lentiviral vector overexpress-
ing a constitutively active PKA (PKA-CQR), when compared to
FSH (Escamilla-Hernandez et al., 2008a), suggesting again that
both PKA-dependent and PKB-dependent signaling pathways are
required for full FSH biological activity.
Consistent with the idea of Gαs-independent transduction
mechanisms at the FSHR, it has been reported that this recep-
tor couples to other G protein subtypes. Indeed, FSHR has been
demonstrated to trigger pertussis toxin-sensitive pathways upon
activation by certain hormonal variants (Arey et al., 1997) or in
particular developmental stage of the target cells (Crépieux et al.,
2001). In addition, the FSHR has also been shown to activate the
inositol trisphosphate (IP3) signaling pathway, particularly at high
doses of agonist (Quintana et al., 1994). Consistentwith these data,
FSHR directly interacts with Gαq subunit overexpressed in granu-
losa cells (Escamilla-Hernandez et al., 2008b).An alternative trans-
duction mechanism has been reported in Sertoli cells and could
also explain the observed FSH-induced IP3 response. According to
this mechanism, FSHR functionally couples to Gαh, also known
as tissue transglutaminase, which leads to PLCδ activation and IP3
accumulation (Lin et al., 2006).
Beside heterotrimeric G proteins, two protein families have
been reported to speciﬁcally interact with the FSHR upon FSH
stimulation: G protein-coupled receptor kinases (GRKs) and β-
arrestins. Originally, GRKs and β-arrestins have been shown to
control the desensitization, internalization, and recycling of FSHR
(Nakamura et al., 1998; Lazari et al., 1999; Troispoux et al., 1999;
Reiter et al., 2001; Kishi et al., 2002; Marion et al., 2002, 2006;
Krishnamurthy et al., 2003a,b; Piketty et al., 2006). Over the last
10 years, the perception of β-arrestins’ functions has expended
as they have been shown to act as G protein-independent signal
transducers at many 7TMRs (Lefkowitz and Shenoy, 2005; Reiter
and Lefkowitz, 2006) including the FSHR (Kara et al., 2006;Wehbi
et al., 2010a,b; Tranchant et al., 2011). In the case of the FSHR, β-
arrestin-dependent and G protein-independent activation of ERK
and rpS6 have been reported so far. However, it is likely that β-
arrestins are involved in the G protein-independent activation of
a wide array of signaling pathways at the FSHR since they act as
multifunctional scaffolds interacting with many protein partners
(Xiao et al., 2007) and facilitating the phosphorylation of numer-
ous intracellular targets (Xiao et al., 2010) at other 7TMRs (see
Whalen et al., 2011 for a recent review).
The adaptor protein containing a PH domain, PTB domain,
and leucine zipper motif 1 (APPL1) has also been reported to
bind directly to the FSHR and trigger downstream signaling
mechanisms. APPL1 has been suggested to interact with the ﬁrst
intracellular loop of the FSHR and to mediate FSH-dependent
PI3K signaling (Nechamen et al., 2004). Recently, Thomas et al.
(2011) have shown that the interaction of APPL1 with the FSHR
is required for the activation of the inositol–phosphate calcium
Frontiers in Endocrinology | Cellular Endocrinology October 2011 | Volume 2 | Article 45 | 2
Gloaguen et al. Mapping the follicle-stimulating hormone-induced signaling networks
FIGURE 1 | Multiple transduction mechanisms induced at the FSHR.
The Gαs/cAMP/protein kinase A (PKA) signaling pathway has classically
been considered as the key signaling mechanism triggered at the FSHR.
Over the last decade, mounting evidence have shown that FSHR also
engages other transduction mechanisms mainly coupling to other Gα
subunits, β-arrestin-dependent signaling, EGFR transactivation, and
APPL1-mediated signals. Bibliographic references are indicated on the map
by the ﬁrst author’s name with two digits for the year of publication. The
CellDesigner program has been used to represent signaling pathways as
shown in Figures 1–7. Complexes are surrounded by a box. Dashed lines
indicate indirect reactions. The following semantic has been used: proteins
( ); active protein ( ); receptor ( ); transcript ( ); gene
( ); catalysis ( ); association ( ); dissociation ( ); inhibition
( ); phosphorylation ( ); degradation ( ); known transition omitted
( ); unknown transition ( ).
pathways upon FSH exposure. In addition, Src family members
have also been reported to induce the PI3K pathway in granulosa
cells (Wayne et al., 2007) and the ERK pathway in both Sertoli and
granulosa cells (Crépieux et al., 2001; Cottom et al., 2003) upon
FSH exposure.
Transactivation of the epithelial growth factor receptor (EGFR)
also seems to play a role in the transmission of FSH signal within
the target cells. Indeed, FSH has been shown to trigger EGFR
autophosphorylation in granulosa cells through the activation of
Src (Cottom et al., 2003; Wayne et al., 2007). Moreover, when
EGFR is inhibited, a decrease in the ability of FSH to induce
ERK or Akt phosphorylation and CDK4 activation has been
observed in various models (Cottom et al., 2003; Andric and
Ascoli, 2006; Shimada et al., 2006; Yang and Roy, 2006; Wayne
et al., 2007).
In the remaining of this review, detailed topological maps for
these different transduction mechanisms and their downstream
signaling cascades will be presented and discussed.
THE CANONICAL GαS-DEPENDENT PATHWAY
As already stated, the Gαs pathway has been the most studied
and is associated with various intracellular events (Figure 2).
Upon FSH activation, FSHR functionally couples to Gαs sub-
unit which in turn induces adenylate cyclase activity (Northup
et al., 1980). The adenylate cyclase-mediated cAMP production is
counterbalanced by phosphodiesterase (PDE) activity (Fakund-
ing et al., 1976). Accumulated cAMP binds to and activates two
distinct downstream effectors: PKA and EPAC.
Upon cAMP binding, PKA’s catalytic subunits are released
and activated (Rangel-Aldao and Rosen, 1976; Landmark et al.,
1991). Active catalytic subunits of PKA subsequently phosphory-
late a number of targets, either in the cytosol, or in the nucleus.
Nuclear actions of PKA are treated in a separate section of this
review. In the cytosol, FSH-induced ERK MAPK activation has
been shown in several models to be sensitive to PKA inhibition
(Crépieux et al., 2001; Kara et al., 2006). Two somehow contradic-
tory mechanisms have been proposed to explain PKA-mediated
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FIGURE 2 | Canonical Gαs/cAMP/PKA pathway at the FSHR.The
Gαs/cAMP/PKA pathway has been the most studied and is associated with
various intracellular events. It is now acknowledged that PKA is not the sole
target of cAMP accumulation. Indeed, EPAC is also activated upon FSH
stimulation. Both PKA and EPAC contribute to the activation of MAPK ERK
and p38, whereas EPAC also leads to Akt activation.
activation of ERK upon FSH stimulation. First, PKA-mediated
phosphorylation of a protein phosphatase (PTP) has been shown
to disrupt the PTP/ERK complex, thereby leading to an increase
in ERK phosphorylation with MEK being constitutively phos-
phorylated (Cottom et al., 2003). Second, it has been reported
that PKA promotes Raf1 activation, which in turn activates MEK
and ﬁnally ERK (Yang and Roy, 2006; Ongeri et al., 2007). Fur-
ther studies will be necessary to clarify this situation. In addi-
tion, PKA inhibition has also been shown to impair FSH-induced
MAPK p38 phosphorylation and the associated cell rounding and
steroidogenesis in granulosa cells (Maizels et al., 1998; Yu et al.,
2005).
Evidence have been provided that EPAC acts as an effector
downstream of FSH-induced cAMP accumulation. Upon cAMP
binding, EPAC promotes Rap1-GDP to GTP exchange and its sub-
sequent activation in granulosa (Wayne et al., 2007) and in surface
epithelium ovary (Choi et al., 2009) cells. Once activated, Rap1
relays FSH-dependent activation of Akt, p38, and ERK (Wayne
et al., 2007; Choi et al., 2009). Again, further investigation will be
necessary in order to delineate the exact contributions of PKA and
EPAC in FSH signaling.
THE β-ARRESTIN-DEPENDENT PATHWAY
Initially, the β-arrestin pathway was viewed as controlling FSHR’s
desensitization and recycling. Similar to many other 7TMRs, this
perception has progressively evolved toward a more general role
of β-arrestins as adapters and transducers (Reiter and Lefkowitz,
2006; Figure 3).
The FSHR has been reported to be phosphorylated by GRKs 2,
3, 5, and 6 upon FSH binding to the receptor in various models
(Nakamura et al., 1998; Lazari et al., 1999; Troispoux et al., 1999;
Marion et al., 2002; Krishnamurthy et al., 2003a; Kara et al., 2006).
A cluster of ﬁve serines and threonines located in the C terminus
of the FSHR has been shown to account for the bulk of FSH-
induced phosphorylation as a result of GRK2 action (Kara et al.,
2006). It is also well documented that β-arrestins are recruited to
theGRK-phosphorylated and agonist-occupied FSHR (Nakamura
et al., 1998; Lazari et al., 1999; Troispoux et al., 1999; Marion et al.,
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FIGURE 3 | FSH-induced β-arrestin-dependent signaling. Initially, the
perception of β-arrestins’ role was restricted to the control of FSHR’s
desensitization and recycling. This view has progressively evolved toward a
more general role of β-arrestins as adapters and transducers leading to the
activation of MAPK ERK and rpS6 independently of G proteins upon FSH
stimulation. GRK2/3 and GRK5/6 control the fate of the activated FSHR (i.e.,
desensitization vs. signaling) presumably through phosphorylation of distinct
serines and threonines within the receptor’s C-tail.
2002; Krishnamurthy et al., 2003a; Kara et al., 2006). In addi-
tion to GRK2-dependent phosphorylation, which plays a major
role in FSHR phosphorylation and β-arrestin recruitment, GRK5
and 6 have also been found to contribute to the same processes in
HEK293 cells, though to a lesser extent (Kara et al., 2006). Interest-
ingly, β-arrestins recruited to GRK2- or GRK5/6-phosphorylated
FSHR have been suggested to exert distinct intracellular functions
(Kara et al., 2006; Reiter and Lefkowitz, 2006). It is well estab-
lished that β-arrestin 1 and 2 binding to GRK-phosphorylated
FSHR leads to the internalization and recycling of the receptor
(Nakamura et al., 1998; Lazari et al., 1999; Kishi et al., 2002;
Kara et al., 2006; Piketty et al., 2006). In HEK293 cells, GRK2-
phosphorylated FSHR has been reported to predominate in the
β-arrestin-mediated internalization process (Kara et al., 2006).
Whilemost of the internalized FSHR is recycled back to the plasma
membrane, a modest proportion of the receptor is routed to
the lysosomal degradation pathway (Krishnamurthy et al., 2003b;
Kluetzman et al., 2011).
A growing number of 7TMRs, including the FSHR, have been
demonstrated to elicit signals independently of heterotrimeric G
protein coupling, throughdirect interactionwith β-arrestins (Kara
et al., 2006; Reiter and Lefkowitz, 2006;Wehbi et al., 2010a,b; Tran-
chant et al., 2011). G protein-mediated ERK activation is rapid
(reaching a maximum within ∼2–5min) and transient. In con-
trast, ERK activation via β-arrestins is slower in onset (reaching
a maximum within ∼5–10min) but sustained (t1/2> 1 h; Kara
et al., 2006). In addition,β-arrestins have been shown to contribute
to rpS6 phosphorylation in HEK293 cells upon FSHR activation
(Wehbi et al., 2010b). As also reported for other 7TMRs, GRK5
and 6-induced phosphorylation of the activated FSHR is required
for β-arrestin-dependent signaling pathway in HEK293 cells (Kara
et al., 2006;Reiter andLefkowitz,2006). Interestingly,partially deg-
lycosylated equine LH has recently been shown to preferentially
activate β-arrestin-dependent signaling at the FSHR, presumably
acting as a biased ligand at this receptor (Wehbi et al., 2010b;
Ulloa-Aguirre et al., 2011).
THE PI3K/mTOR PATHWAY
An array of evidence, gathered in various cell models, supports the
notion that the PI3K/mTOR pathway plays an important role in
FSH-induced actions including proliferation, regulation of gene
transcription as well as of protein translation (Figure 4). FSH
has been shown to lead to PI3K activation, PIP3 accumulation,
and FSH-dependent proliferation in both granulosa cells and pri-
mary Sertoli cells from newborn rat (Park et al., 2005; Musnier
et al., 2009; Dupont et al., 2010). Interestingly, in differentiating
rat Sertoli cells,PIP3 accumulation is negatively regulatedbyPTEN
whose expression is strongly and rapidly induced upon FSH stim-
ulation, which results in a blockade of FSH-induced proliferation
(Dupont et al., 2010).
This FSH-induced PI3K/PIP3 pathway has been reported by
numerous authors to trigger Akt phosphorylation and activation
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FIGURE 4 | PI3K/mTOR signaling at the FSHR.The PI3K/mTOR pathway plays an important role in FSH-induced actions, including proliferation, regulation of
gene transcription as well as of protein translation.
(Gonzalez-Robayna et al., 2000; Alam et al., 2004, 2009; Meroni
et al., 2004; Nechamen et al., 2004; Park et al., 2005; McDonald
et al., 2006; Chen et al., 2007; Fan et al., 2008, 2010). In turn Akt
leads to GSK3β phosphorylation and deactivation (Alam et al.,
2009; Fan et al., 2010). It also triggers AMPK phosphorylation
and its deactivation (Kayampilly and Menon, 2009). In addition,
Akt has been reported to inactivate FoxO3a (Chen et al., 2007)
and FoxO1 (Cunningham et al., 2003; Nechamen et al., 2004; Park
et al., 2005; Chen et al., 2007; Fan et al., 2008; Musnier et al.,
2009), two transcription factors which differentially impact on
gene regulation.
The PI3K/PIP3 pathway has also been shown to induce mTOR
phosphorylation and activation (Chen et al., 2007; Musnier et al.,
2009). Another mechanism contributing to the full activation of
mTORupon FSH stimulation involves ERK activationwhich leads
to TSC2 phosphorylation, thereby releasing its negative regulation
on Rheb. Rheb-GTP in turn induces mTOR activity (Alam et al.,
2004; Lécureuil et al., 2005; Kayampilly and Menon, 2007).
Once activated, mTOR controls p70S6K activity (Alam et al.,
2004; Lécureuil et al., 2005; Chen et al., 2007; Kayampilly and
Menon, 2007; Musnier et al., 2009). Active mTOR also leads to
the phosphorylation and inactivation of 4E-BP1, a factor nega-
tively controllingprotein translation (Alamet al.,2004). Inparallel,
FSH-induced p70S6K activity triggers a robust phosphorylation of
rpS6 (Alam et al., 2004; Lécureuil et al., 2005;Musnier et al., 2009).
The combination of rpS6 activation and 4E-BP1 inhibition sup-
port the notion that FSH controls and activates protein translation
in addition to its well-known effects on gene expression.
FSHR INTERACTING PROTEINS
A number of proteins has been reported to interact with the FSHR
and to impact on FSH-induced signaling pathways (Dias et al.,
2005). One of the alternative transduction mechanism used by
the FSHR involves the APPL1 (Figure 5). APPL1 has been shown
to interact with the ﬁrst and second intracellular loop of the
FSHR, and has been proposed to mediate FSH-dependent PI3K
and Akt signaling (Nechamen et al., 2004). Furthermore, recent
studies in HEK293 cells and KGN granulosa cells have shown that
residues K376, L377, and F382 in the ﬁrst intracellular loop of
the FSHR are implicated in the interaction of the receptor with
APPL1 and that K376 particularly, links the activated FSHR to
the inositol–phosphate pathway and FSH-stimulated intracellular
calcium mobilization (Thomas et al., 2011). Other studies have
reported calcium accumulation upon FSH stimulation in differ-
ent cell models (Flores et al., 1990; Jayes et al., 2000; Lin et al., 2006;
Lai et al., 2008). Further studies will be necessary to determine to
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FIGURE 5 | Proteins interacting at the FSHR and their role in signaling. A number of proteins have been reported to interact with the FSHR and to impact
on FSH-induced signaling pathways.These include 14-3-3τ, FoxO1, and APPL1, the latter two being involved in the control of the PI3K/Akt pathway downstream
of the FSHR.
what extent APPL1/FSHR interaction is a general requirement for
FSH-induced calcium signaling.
A direct interaction between the transcription factor FoxO1a
and the FSHR has been evidenced (Nechamen et al., 2007). It has
been suggested that,while interactingwith the FSHR,FoxO1a can-
not translocate to the nucleus and affect gene transcription (Dias
et al., 2010). Interestingly, APPL1 also potentially contributes to
the nuclear exclusion of FoxO1a though a distinct mechanism.
Indeed, APPL1-mediated PI3K activation leads to Akt-dependent
phosphorylation of FoxO1a, impairing its nuclear localization.
It has been proposed that FoxO1a phosphorylation could occur
within FSHR-containing signalosome since APPL1 is well-known
to interact with Akt (Dias et al., 2010).
The FSHR interacts with the scaffolding protein 14-3-3τ
(Cohen et al., 2004). This interaction has been mapped in the
second intracellular loop, in a region encompassing the ERW
motif, where it is predicted to compete with Gαs coupling. Consis-
tently, when overexpressed, 14-3-3τ has been reported to dampen
FSH-induced cAMP accumulation (Cohen et al., 2004; Dias et al.,
2010).
EGFR TRANSACTIVATION
Similar to other GPCRs, many lines of evidence point to EGFR
transactivation as an important transduction mechanism used by
FSHR (Cottom et al., 2003; McDonald et al., 2006; Figure 6). Two
mechanisms have been shown to contribute to EGFR activation
upon FSH stimulation. First, the metalloprotease ADAM17 has
been shown to be phosphorylated in response to FSH stimulation
(Yamashita et al., 2007, 2009, 2010). Once activated, ADAM17
splits a pro-EGF-like protein, releasing an EGF-like ligand which
subsequently binds to and activates EGFR (Yamashita et al., 2007).
The mechanism by which FSHR induces ADAM17 phosphory-
lation is not yet identiﬁed. However, data from other receptors
suggest that either p38 (Xu and Derynck, 2010) or Src (Zhang
et al., 2006) could be involved in this process. A second mech-
anism of EGFR transactivation by the FSHR involves Src which
has been proposed to be activated upon FSH exposure and to
directly phosphorylate EGFR thereby eliciting EGF-independent
activation of this receptor (Wayne et al., 2007).
When EGFR activation is pharmacologically inhibited, a sig-
niﬁcant decrease in phosphorylated ERK is observed (Cottom
et al., 2003; Andric andAscoli, 2006; McDonald et al., 2006;Wayne
et al., 2007; Shupe et al., 2011). EGFR transactivation activates Ras
which in turn induces the Raf1/MEK/ERK MAP kinase module,
ultimately resulting in ERK phosphorylation (Cottom et al., 2003;
Andric andAscoli, 2006;McDonald et al., 2006;Ongeri et al., 2007;
Wayne et al., 2007; Shupe et al., 2011). In granulosa cells, it has been
shown that, upon sustained FSH exposure, a self-activation loop
involving the MAP kinase module as well as phospholipase A2 and
PKC, leads to CDK4 stimulation, retinoblastoma (RB1) inactiva-
tion, and ultimately DNA synthesis (Yang and Roy, 2006). EGFR
transactivationhas alsobeen reported to triggerPI3K (Wayne et al.,
2007).
NUCLEAR EVENTS CONTROLLED BY FSH
For simpliﬁcation purpose, we decided to aggregate all the knowl-
edge accumulated in the literature about FSH-induced nuclear
events in a separate map (Figure 7). Gene transcription has
long been known to be affected by FSH, as the hormone is
known to control for instance genes implicated in steroidogenesis
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FIGURE 6 |Transactivation of the EGFR by FSH. Many lines of evidence
point to EGFR transactivation as an important transduction mechanism used
by FSHR. Two mechanisms have been reported: ﬁrst, FSH stimulates the
ADAM17 metalloprotease that leads to the release of an EGF-like ligand,
which subsequently binds to and activates EGFR; second, FSH activates Src
which directly phosphorylates EGFR, thereby eliciting EGF-independent
activation of this receptor. MAPK ERK and PI3K pathways have been shown
to be activated as a result of EGFR transactivation by FSHR.
(Escamilla-Hernandez et al., 2008a) or in cell cycle via Smad
proteins (Wang et al., 2011).
Upon FSH activation, PKA catalytic subunit translocates to
the nucleus, where it activates CREB through phosphorylation
on S133, thereby controlling cAMP response element (CRE)-
containing genes (Cottom et al., 2003; Fan et al., 2010). It also
promotes the recruitment of the activator protein 1 (AP1) tran-
scription factor to their cognate promoter regions (Yang et al.,
2008). Nuclear PKA also leads to histone H3 phosphorylation and
acetylation (Salvador et al., 2001). Histone H3 phosphorylation
is known to favor cell division (Hans and Dimitrov, 2001) and
ChIP experiments have revealed FSH-induced interactionbetween
phosphorylated, acetylated histone H3 and the promoter region
of c-Fos, a well-known signal transducer of cell proliferation and
differentiation (Salvador et al., 2001). Interestingly, it has recently
been reported that cytosolic PKA is able to bind the retinoic acid
receptor alpha (RARA) and by doing so, to inhibit RARA translo-
cation to the nucleus, hence the effects this nuclear receptor exerts
on gene transcription (Santos and Kim, 2010).
Akt controls the activity of several transcription factors through
PKA-independent mechanisms. Akt has been reported to suppress
the inhibition of some transcription factors and to inhibit the
activity of some others. For example, upon FSH exposure, Akt
phosphorylates FoxO1a which is then excluded from the nucleus
and is not able to inhibit MDM2-dependent HIF-1α activation
anymore (Nechamen et al., 2004; Park et al., 2005; Chen et al.,
2007; Fan et al., 2008; Alam et al., 2009). Akt also phosphory-
lates FoxO3a provoking its exclusion from the nucleus, blocking
the pro-apoptotic effects of this transcription factor (Chen et al.,
2007). In addition, Akt has been reported to promote GSK3β
phosphorylation and deactivation which indirectly favors LEF-
dependent transcription (Gonzalez-Robayna et al., 2000; Fan et al.,
2010). The nuclear translocation of NFκB is also promoted by Akt
(Wang et al., 2002).
Once phosphorylated,MAP kinases ERK and p38 affect various
transcriptional regulations in the nucleus (Cameron et al., 1996),
participating to the regulation of AP1 and CREB activities.
FUTURE DIRECTIONS
Reconstructing the very complex intracellular networks triggered
by FSH from the literature represents a huge challenge, partly
due to the tremendous heterogeneity of experimental approaches
and models, and partly because of the subjectivity and “bias”
which cannot be avoidedwhenmanually assembling such network
topologies. In the future, automated methods will probably allow
building complex networks from the available data in a completely
unbiased manner. In parallel, mass-spectrometry-based high-
throughput methods now allow to grasp the phosphoproteome
with an unprecedented power and in an unbiased fashion. Data
generated using such experimental approaches will soon become
available for FSH-responsive cells and will probably deliver an
exhaustive coverage of the FSH-mediated signaling mechanisms
induced in different cellular context. It will also be of importance
to continue to bridge the gap between intracellular signaling path-
ways and integrated cellular responses such as gene regulation,
metabolism, differentiation, proliferation, or apoptosis. Once the
architecture of the FSH-induced signaling network will be deci-
phered, dynamical modeling will allow numerical simulations to
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FIGURE 7 | Nuclear events controlled by FSH. Gene transcription has long been known to be affected by FSH. Multiple signaling pathways that are activated
upon stimulation (i.e., PKA, p38, ERK, and Akt) subsequently trigger the activation or suppression of various transcription factors’ activities at the nuclear level.
be carried out and functional prediction to be made. In that
context, the generation of high quality dynamical data of the key
FSH-induced signaling events will likely become a prerequisite in
order to calibrate and validate the dynamical models.
Together, these technological breakthroughs will likely help
reconstructing the global FSH-induced signaling mechanisms,
predicting the way it processes information and delivers adapted
physiological outcomes. It is expected that all these computa-
tional resources will help rationalize the development of pathway-
selective pharmacological approaches at the FSHR. In addition,
several genetic studies have reported a number of mutations and
polymorphisms in the FSHR. Until now, the functional con-
sequences of these genetic alterations were evaluated solely by
measuring their effects on the classical Gs/cAMP/PKA pathway.
However, as we have recently shown for the A189V mutation
of the FSHR, multiplexed assessment of the mutants’ and/or
variants’ functionality can allow uncovering subtle perturba-
tions/imbalances within the signaling networks (Tranchant et al.,
2011). Therefore,with the availability of computational and exper-
imental tools, it will become possible to achieve better assessment
of the real functional impact of genetic alterations encountered,
not only in the FSH or FSHR but also anywhere within the
activated networks.
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